USFDA approval of Amgen’s Aimovig for preventive treatment of migraine in adults
Amgen has got US Food and Drug Administration (FDA) approval for Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. Aimovig... Read More
What is placebo effect in clinical trial?
A placebo is a substance or treatment with no active therapeutic effect. Common placebos include inert tablets (like sugar pills), inert injections... Read More
“A Phase 3 trial is randomized, double-blind, and placebo-controlled” – What it signifies?
“A Phase 3 trial is randomized, double-blind, and placebo-controlled” – What it signifies? We sometime confuse the terminologies of clinical trial and... Read More
US WorldMeds’ Lucemyra received US FDA approval for management of opioid withdrawal symptoms
US WorldMeds announced that the US Food and Drug Administration (FDA) approved Lucemyra (lofexidine) for mitigation of opioid withdrawal symptoms to facilitate... Read More
Alcon Cares Project 100 commits to reducing cataract blindness globally
Alcon, the global leader in eye care and a division of Novartis, has announced Alcon Cares Project 100, which aims to reduce... Read More
Licensing Deal: Hikma Pharma launches Basilea’s antibiotic Zevtera in Saudi Arabia
Basilea Pharmaceutica Ltd. announced that its partner Hikma Pharmaceuticals LLC has launched Basilea’s hospital antibiotic Zevtera (ceftobiprole) in Saudi Arabia in first... Read More
Medical Science Liaison (MSL) – A Career Option for Healthcare Professionals !
What is The Medical Science Liaison (MSL)? The Medical Science Liaison (MSL) is a specific job related role within the healthcare industries, e.g.... Read More
A close look into New Drug Development Timeline – Fingolimod
Posted on15 May 2018
Comments0
Fingolimod is an immunomodulating drug, mostly used for treating multiple sclerosis (MS). It has reduced the rate of relapses in relapsing-remitting multiple... Read More
Novartis’ Gilenya receives US FDA approval to treat MS in paediatric patients
Novartis announced that the US Food and Drug Administration (FDA) has approved Gilenya (fingolimod) for the treatment of children and adolescents 10... Read More
Big Pharma Acquisition: Takeda to acquire Shire for $62 billion
Takeda Pharmaceutical Co. of Japan has finalized an agreement to buy Shire PLC, the second-biggest biotech employer in Massachusetts, for $62 billion... Read More